November 30, 2020

The Niche

Knoepfler lab stem cell blog

Geron CIRM

2 min read

CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company in support of a clinical trial and represents a major milestone.  The funding should help Geron accelerate the clinical trial and is wonderful news. You can read the grant …Read More